Insurers won’t cover new Alzheimer’s treatment for some customers ...Middle East

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, told The Associated Press they won’t cover Leqembi with insurance offered on the individual market and through employers because they still see the $26,000-a-year drug as experimental. Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug. The federal coverage program mainly for people ages 65 and older announced shortly after Leqembi received full approval last month that it will cover the treatment while still tracking its

Read More Details
Finally We wish PressBee provided you with enough information of ( Insurers won’t cover new Alzheimer’s treatment for some customers )

Also on site :

• 105 'Magical' Baby Names for Your Little Spell Caster
• Josh Paul resigned over Gaza. What comes next?
• ‘Honey Don’t!’ Review: Margaret Qualley, Aubrey Plaza and Chris Evans Get Stranded in Ethan Coen’s Wayward Whodunit